(Q50936610)

25 March 2018

title

Differentiation of hUC-MSC into dopaminergic-like cells after transduction with hepatocyte growth factor. (English)

1 reference

25 March 2018

human umbilical cord mesenchymal stem cell

1 reference

1 reference

Jin-Feng Li

1

1 reference

25 March 2018

Hong-Lei Yin

2

1 reference

25 March 2018

Adam Shuboy

3

1 reference

25 March 2018

Hai-Feng Duan

4

1 reference

25 March 2018

Ji-Yu Lou

5

1 reference

25 March 2018

Jing Li

6

1 reference

25 March 2018

Hong-wei Wang

7

1 reference

25 March 2018

Yun-Liang Wang

8

1 reference

25 March 2018

publication date

5 June 2013

1 reference

25 March 2018

Molecular and Cellular Biochemistry

published in

1 reference

25 March 2018

volume

381

1 reference

25 March 2018

issue

1-2

1 reference

25 March 2018

page(s)

183-190

1 reference

25 March 2018

Apathy in Parkinson's disease.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Cell therapy for Parkinson's disease: what next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Neural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Molecular aspects of dopaminergic neurodegeneration: gene-environment interaction in parkin dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

The effect of onset age on the clinical features of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Review: management of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

21 January 2018

Hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Identification of HGF-like protein as a novel neurotrophic factor for avian dorsal root ganglion sensory neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Hepatocyte growth factor/scatter factor is a motogen for interneurons migrating from the ventral to dorsal telencephalon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Combined omics analysis identifies transmembrane 4 L6 family member 1 as a surface protein marker specific to human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Parkinson's disease or Parkinson symptoms following seasonal influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Milestones in Parkinson's disease therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Stem cell aging and plasticity in the Drosophila nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Does Parkinson's disease have an immunological basis? The evidence and its therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Hepatocyte growth factor promotes proliferation and migration in immortalized progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Prevention of onset of Parkinson's disease by in vivo gene transfer of human hepatocyte growth factor in rodent model: a model of gene therapy for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Transcriptional and post-transcriptional regulation of tyrosine hydroxylase messenger RNA in PC12 cells during persistent stimulation by VIP and PACAP38: differential regulation by protein kinase A and protein kinase C-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Dopamine transporter (Dat) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

DAT imaging in drug-induced and psychogenic parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Diagnosing premotor Parkinson's disease using a two-step approach combining olfactory testing and DAT SPECT imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

T-cadherin is present on endothelial microparticles and is elevated in plasma in early atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1701-Z

Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor

21 January 2018

1 reference

12 December 2020

Characterization of human adipose-derived stem cells.

1 reference

12 December 2020

Expression of hepatocyte growth factor in the serum and cerebrospinal fluid of patients with Parkinson’s disease

1 reference

12 December 2020

Expression of HGF and cMet in the peripheral nervous system of adult rats following sciatic nerve injury

1 reference

12 December 2020

Alpha-synuclein induces apoptosis by altered expression in human peripheral lymphocyte in Parkinson's disease

1 reference

12 December 2020

Hepatocyte growth factor protects human embryonic stem cell derived-neural progenitors from hydrogen peroxide-induced apoptosis

1 reference

12 December 2020

Isolation, culture, and characterization of human umbilical cord stroma-derived mesenchymal stem cells

1 reference

12 December 2020

10.1007/S11010-013-1701-Z

Identifiers

DOI

1 reference

25 March 2018

1 reference

25 March 2018